Anton Paar has announced the launch of the Litesizer DLS 301, the latest addition to its established Litesizer family.

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) to enhance pharmaceutical education and research ...

Following a difficult year that saw Ixchiq’s license suspended in the US, Valneva is pinning hopes on upcoming pipeline ...

Novartis has signed a research partnership and licensing agreement with Unnatural Products (UNP) valued at up to $1.7bn.

Industry and US administration leaders lay out their plans to navigate a globally competitive pharma landscape with China’s ...

MSD and Mayo Clinic have entered a R&D collaboration to use AI, advanced analytics, and clinical data in support of drug ...

As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...

J&J has received the US FDA approval for a new monthly dosing schedule for the combination therapy Rybrevant Faspro to treat ...

Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes.

Outgoing Merck KGaA CEO Belén Garijo is set take the helm at Sanofi, after the French vaccine specialist announced it would ...

Ampersand Capital Partners has acquired Purna Pharmaceuticals, a Belgium based provider of development and manufacturing ...

THX Pharma and Biocodex have entered into a strategic licensing agreement to further the development of two drug candidates, ...